Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBicara Therapeutics Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

Bicara Therapeutics Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 8, 2026Cohlhepp RyanPresident, COO & Interim CEO17,500Common Stock$405.5KSell
Sep 8, 2026Cohlhepp RyanPresident, COO & Interim CEO17,500Common Stock$405.5KOption exercise
Aug 12, 2026Larson JenniferChief Financial Officer285,000Stock Option (Right to Buy)$8MGrant / award
Aug 10, 2026Cohlhepp RyanPresident and COO18,750Common Stock$526.1KSell
Aug 10, 2026Cohlhepp RyanPresident and COO18,750Common Stock$526.1KOption exercise
Aug 10, 2026Mazumdar ClaireChief Executive Officer10,000Common Stock$280.6KSell
Aug 10, 2026Mazumdar ClaireChief Executive Officer10,000Common Stock$280.6KOption exercise
Aug 10, 2026Hyep IvanChief Financial Officer12,500Common Stock$350.8KSell
Aug 10, 2026Hyep IvanChief Financial Officer12,500Common Stock$350.8KOption exercise
Jul 28, 2026Oliger Christy J.Director38,950Stock Option (Right to Buy)$1.1MGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$22.78Close · Sep 22, 2026